DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Lidocaine; tetracaineis the generic ingredient in two branded drugs marketed by Taro Pharms and Galen Specialty, and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Lidocaine; tetracaine has seven patent family members in seven countries.
There are twenty-nine drug master file entries for lidocaine; tetracaine. Three suppliers are listed for this compound.
Recent Clinical Trials for lidocaine; tetracaine
Identify potential brand extensions & 505(b)(2) entrants
|Mayo Clinic||Phase 2/Phase 3|
|Children's Hospital of Orange County||Phase 4|
|McGill University Health Center||N/A|